NCT03526302View on ClinicalTrials.gov

TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Sudden Cardiac Death
Trial Locations (1)

80636

Deutsches Herzzentrum München, München

All Listed Sponsors
lead

Deutsches Herzzentrum Muenchen

OTHER

NCT03526302 - TroponinT After Subcutaneous Cardioverter-Defibrillator Implantation | Biotech Hunter | Biotech Hunter